Institut Carnot Curie Cancer
Share
Since 2011, Institut Curie is certified as “Institut Carnot Curie Cancer”. The Carnot label is a label of excellence granted to public research structures with proven, high level R&I competencies dedicated to fostering innovation with industrial partners. Institut Carnot Curie Cancer offers to industrial partners the possibility of setting-up research collaborations, to go from identification of therapeutic target to the clinical validation of a drug.
FROM THERAPEUTIC TARGET TO CLINICAL VALIDATION
Institut Carnot Curie Cancer offers industrial partners the possibility to set up research collaborations to go from the identification of a therapeutic target to the clinical validation of a drug. For Institut Curie, the Carnot label is a token of:
- Expertise
Institut Curie must maintain world-class expertise in the field of oncology. The Carnot initiative makes it possible to gather the critical mass needed to create leverage and drive this state-of-the-art research dynamic.
- Collaborations
Institut Curie must position itself to focus on the exchange of expertise and know-how. The Carnot initiative allows for transverse projects that encourage this.
SOURCING INNOVATIVE PROJECTS
The Carnot initiative supports innovative projects that otherwise would not be funded. The data collected reduce investment risks of others funding sources that would take in charge the next steps of the most promising opportunities. Carnot institutes network represents 50% of the national activity in partnership research now brings together more than 13,000 researchers.
Share